[1]
|
WHO (2005) Expert Consultation on Rabies. Geneva.
|
[2]
|
Finke, S. and Conzelmann, K.K. (2005) Replication Strat-egies of Rabies Virus. Virus Research, 111, 120-131.
https://doi.org/10.1016/j.virusres.2005.04.004
|
[3]
|
Pasteur, L., Chamberland, C. and Roux, P.P.E. (1884) Nouvelle Communication sur la rage. Comptes rendus de l’Académie des Sciences (Paris), 98, 457-463, 1229-1231.
|
[4]
|
Louis Pasteur, N.J. (1962) A Master of Scientific Enquiry. The Scientific Book Guild, London.
|
[5]
|
Javier, R.S., Kunishita, T., Koike, F. and Tabira, T. (1989) Semple Rabies Vaccine: Presence of Myelin Basic Protein and Proteolipid Protein and Its Activity in Experimental Allergic Encephalomyelitis. Journal of the Neurological Sciences, 93, 221-230. https://doi.org/10.1016/0022-510X(89)90192-5
|
[6]
|
Fuenzalida, E., Palacios, R. and Borgono, J.M. (1964) Anti-Rabies Antibody Response in Man to Vaccine Made from Infected Suckling-Mouse Brains. Bulletin of the World Health Organization, 30, 431-436.
|
[7]
|
Peck, F.B., Powell, H.M. and Culbertson, C.G. (1956) Duck-Embryo Rabies Vaccine: Study of Fixed Virus Vaccine Grown in Embryonated Duck Eggs and Killed with Beta-Propiolactone. JAMA, 162, 1373-1376.
https://doi.org/10.1001/jama.1956.02970320021006
|
[8]
|
Gluck, R., Wegmann, A., Germanier, R., Keller, H., Hess, M.W., Kraus-Ruppert, R. and Wandeler, A.I. (1984) A New, Highly Immunogenic Duck Embryo Rabies Vaccine. The Lancet, 1, 844-845.
https://doi.org/10.1016/S0140-6736(84)92286-4
|
[9]
|
Gluck, R., Matthieu, J.M., Wegmann, A. and Mean, F. (1986) Absence of Myelin Basic Protein in an Improved Purified Duck Embryo Rabies Vaccine. Neurochemical Pathology, 4, 69-75.
|
[10]
|
Kissling, R.E. (1958) Growth of Rabies Virus in Non-Nervous Tissue. Proceedings of the Society for Experimental Biology and Medicine, 98, 223-225. https://doi.org/10.3181/00379727-98-23997
|
[11]
|
Kissling, R.E. and Reese, D.R. (1963) Anti-Rabies Vaccine of Tissue Culture Origin. The Journal of Immunology, 91, 362-368.
|
[12]
|
Wiktor, T.J., Fernandes, M.V. and Koprowski, H. (1964) Cultivation of Rabies Virus in Human Diploid Cell Strain WI-38. The Journal of Immunology, 93, 353-366.
|
[13]
|
Wiktor, T.J., Plotkin, S.A. and Koprowski, H. (1978) Development and Clinical Trials of the New Human Rabies Vaccine of Tissue Culture (Human Diploid Cell) Origin. Developments in Biological Standardization, 40, 3-9.
|
[14]
|
Plotkin, S.A. (1980) Rabies Vaccine Prepared in Human Cell Cultures: Progress and Perspectives. Reviews of Infectious Diseases, 2, 433-448. https://doi.org/10.1093/clinids/2.3.433
|
[15]
|
Wiktor, T.J., Sokol, F., Kuwert, E. and Koprowski, H. (1969) Immunogenicity of Concentrated and Purified Rabies Vaccine of Tissue Culture Origin. Experimental Biology and Medicine, 131, 799-805.
https://doi.org/10.3181/00379727-131-33981
|
[16]
|
Wiktor, T.J., Plotkin, S.A. and Grella, D.W. (1973) Human Cell Culture Rabies Vaccine. Antibody Response in Man. JAMA, 224, 1170-1171. https://doi.org/10.1001/jama.1973.03220220072012
|
[17]
|
Sikes, R.K., Cleary, W.F., Koprowski, H., Wiktor, T.J. and Kaplan, M.M. (1971) Effective Protection of Monkeys against Death from Street Virus by Post-Exposure Admin-istration of Tissue-Culture Rabies Vaccine. Bulletin of the World Health Organization, 45, 1-11.
|
[18]
|
Berlin, B.S., Mitchell, J.R., Burgoyne, G.H., Brown, W.E. and Goswick, C. (1983) Rhesus Diploid Rabies Vaccine (Adsorbed), a New Rabies Vaccine. II. Results of Clinical Studies Simulating Prophylactic Therapy for Rabies Exposure. JAMA, 249, 2663-2665. https://doi.org/10.1001/jama.1983.03330430039026
|
[19]
|
Burgoyne, G.H., Kajiya, K.D., Brown, D.W. and Mitchell, J.R. (1985) Rhesus Diploid Rabies Vaccine (Adsorbed): A New Rabies Vaccine. Using FRhL-2 Cells. The Journal of Infectious Diseases, 152, 204-210.
https://doi.org/10.1093/infdis/152.1.204
|
[20]
|
Berlin, B.S. (1990) Rabies Vaccine Adsorbed: Neutralizing Antibody Titers after Three-Dose Pre-Exposure Vaccination. American Journal of Public Health, 80, 476-477. https://doi.org/10.2105/AJPH.80.4.476
|
[21]
|
Kondo, A. (1965) Growth Characteristics of Rabies Virus in Primary Chicken Embryo Cells. Virology, 27, 199-204.
https://doi.org/10.1016/0042-6822(65)90160-1
|
[22]
|
Nicholson, K.G., Farrow, P.R., Bijok, U. and Barth, R. (1987) Pre-Exposure Studies with Purified Chick Embryo Cell Culture Rabies Vaccine and Human Diploid Cell Vaccine: Se-rological and Clinical Responses in Man. Vaccine, 5, 208-210. https://doi.org/10.1016/0264-410X(87)90102-2
|
[23]
|
Dreesen, D.W., Fishbein, D.B., Kemp, D.T. and Brown, J. (1989) Two-Year Comparative Trial on the Immunogenicity and Adverse Effects of Purified Chick Embryo Cell Rabies Vaccine for Pre-Exposure Immunization. Vaccine, 7, 397-400. https://doi.org/10.1016/0264-410X(89)90152-7
|
[24]
|
Montagnon, B.J. (1989) Polio and Rabies Vaccines Produced in Continuous Cell Lines: A Reality for Vero Cell Line. Developments in Biological Standardization, 70, 27-47.
|
[25]
|
Ajjan, N. and Pilet, C. (1989) Comparative Study of the Safety and Protective Value, in Pre-Exposure Use, of Rabies Vaccine Cultivated on Human Diploid Cells (HDCV) and of the New Vaccine Grown on Vero Cells. Vaccine, 7, 125-128. https://doi.org/10.1016/0264-410X(89)90050-9
|
[26]
|
Gueu, L., Schares, S., Schinck, C., et al. (2008) Genetic Characterization of Attenuated SAD Rabies Virus Strains Used for Oral Vaccination of Wildlife. Vaccine, 26, 3227-3235. https://doi.org/10.1016/j.vaccine.2008.04.007
|
[27]
|
Cliquet, F. and Aubert, M. (2004) Elimination of Terrestrial Rabies in Western European Countries. Developmental Biology, 119, 185-204.
|
[28]
|
Vos, A., Freuling, C., Eskiizmirliler, S., et al. (2009) Rabies in Foxes, Aegean Region, Turkey. Emerging Infectious Diseases, 15, 1620-1622. https://doi.org/10.3201/eid1510.090203
|
[29]
|
Lafay, F., Benejean, J., Tuffereau, C., et al. (1994) Vaccination against Rabies: Construction and Characterization of SAG2, a Double Avirulent Derivative of SADBern. Vaccine, 12, 317-320.
https://doi.org/10.1016/0264-410X(94)90095-7
|
[30]
|
Hooper, D.C., Morimoto, K., Bettle, M., et al. (1998) Col-laboration of Antibody and Inflammation in Clearance of Rabies Virus from the Central Nervous System. Journal of Virology, 72, 3711-3719.
|
[31]
|
Seif, I., Coulon, P., Rollin, P.E., et al. (1985) Rabies Virulence: Effect on Pathogenicity and Sequence Characterisation of Rabies Virus Mutations Affecting Antigenic Site III of the Glycoprotein. Journal of Virology, 53, 926-934.
|
[32]
|
Prehaud, C., Coulon, P., Lafay, F., et al. (1988) Antigenic Site II of Rabies Virus Glyco-protein: Structure and Role in Viral Virulence. Journal of Virology, 62, 1-7.
|
[33]
|
Vidy, A., Chelbi-Alix, M. and Blondel, D. (2005) Rabies Virus P Protein Interacts with STAT 1 and Inhibits Interferon Signal Transduction. Journal of Virology, 79, 14411-14420. https://doi.org/10.1128/JVI.79.22.14411-14420.2005
|
[34]
|
Brzozka, K., Finke, S. and Conzelmann, K.K. (2006) Inhibition of Interferon Signalling by Rabies Virus Phosphoprotein P: Activation-Dependent Binding of STAT1 and STAT2. Journal of Virology, 80, 2675-2683.
https://doi.org/10.1128/JVI.80.6.2675-2683.2006
|
[35]
|
Wen, Y., Wang, H., Wu, H., et al. (2011) Rabies Virus Expressing Dendritic Cell-Activating Molecules Enhances the Innate and Adaptive Immune Response to Vaccination. Journal of Virology, 85, 1634-1644.
https://doi.org/10.1128/JVI.01552-10
|